Clinical Trials Browser

Phase 2 × Lutetium × 30 days × Clear all

NCT05849298 2026-04-13

PSMACare

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT06894511 2026-04-08

PSMAndARPI

Phase 2 Active not recruiting

Metastatic Castration Resistant Prostate Cancer (mCRPC)